RECURRENT CHILDHOOD OSTEOSARCOMA
Clinical trials for RECURRENT CHILDHOOD OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CHILDHOOD OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT CHILDHOOD OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough childhood cancers in new trial
Disease control TerminatedThis early-stage trial tests a personalized cell therapy called GD2CART for children and young adults with neuroblastoma or osteosarcoma that has returned or not responded to standard treatments. The therapy uses the patient's own immune cells (T cells), which are modified in a l…
Matched conditions: RECURRENT CHILDHOOD OSTEOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
New hope for kids with rare cancers: targeted drug shows promise in early trial
Disease control OngoingThis study tested a drug called erdafitinib in children and young adults (ages 1 to 21) whose cancers had come back or were not responding to treatment. The drug targets cancers with specific changes in FGFR genes. The main goal was to see if the drug could shrink tumors. About 2…
Matched conditions: RECURRENT CHILDHOOD OSTEOSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC